newsfilter
← Latest News
Business Wire·

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

Summit Therapeutics Inc. (NASDAQ:SMMT) today announced the successful closing of AstraZeneca’s (NYSE:AZN) strategic equity investment in Summit. The equity investment will support continued acceleration of the